Literature DB >> 22379623

To use or not to use: Expanding the view on non-addictive psychoactive drug consumption and its implications.

Christian P Müller1, Gunter Schumann.   

Abstract

Proposing a change to the view on psychoactive drug use in non-addicts touches a sensitive issue because of its potential implications to addiction prevention, therapeutic practice, and drug policy. Commentators raised nine questions that ranged from clarifications, suggested extensions of the model to supporting data previously not regarded, to assumptions on the implications of the model. Here, we take up the suggestions of the commentators to expand the model to behavioral addictions, discuss additional instrumentalization goals, and review the evidence from laboratory animal studies on drug instrumentalization. We consider further the role of sociocultural factors and individual development in the establishment in drug instrumentalization and addiction. Finally, we clarify which implications we think this model may have. We conclude that drug instrumentalization theory can be further applied to other behaviors but will require a sensitive debate when used for drug and addiction policy that directly affects prevention and treatment.

Mesh:

Year:  2011        PMID: 22379623     DOI: 10.1017/s0140525x1100135x

Source DB:  PubMed          Journal:  Behav Brain Sci        ISSN: 0140-525X            Impact factor:   12.579


  16 in total

Review 1.  The role of sphingolipids in psychoactive drug use and addiction.

Authors:  Liubov S Kalinichenko; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-01-10       Impact factor: 3.575

Review 2.  Non-pharmacological factors that determine drug use and addiction.

Authors:  Serge H Ahmed; Aldo Badiani; Klaus A Miczek; Christian P Müller
Journal:  Neurosci Biobehav Rev       Date:  2018-09-01       Impact factor: 8.989

3.  Episodic memories and their relevance for psychoactive drug use and addiction.

Authors:  Christian P Müller
Journal:  Front Behav Neurosci       Date:  2013-05-23       Impact factor: 3.558

4.  Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics.

Authors:  Sebastian Sattler; Guido Mehlkop; Peter Graeff; Carsten Sauer
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-02-01

5.  Drugs As Instruments: Describing and Testing a Behavioral Approach to the Study of Neuroenhancement.

Authors:  Ralf Brand; Wanja Wolff; Matthias Ziegler
Journal:  Front Psychol       Date:  2016-08-17

6.  Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic - A case report.

Authors:  Elisabeth Müller; Thomas Hillemacher; Christian P Müller
Journal:  Heliyon       Date:  2021-05-10

7.  Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students' everyday life "doping".

Authors:  Wanja Wolff; Ralf Brand
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-06-18

8.  Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement.

Authors:  Sebastian Sattler; Cynthia Forlini; Eric Racine; Carsten Sauer
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  The rationale for consuming cognitive enhancement drugs in university students and teachers.

Authors:  Sebastian Sattler; Carsten Sauer; Guido Mehlkop; Peter Graeff
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

10.  The Complexity of Neuroenhancement and the Adoption of a Social Cognitive Perspective.

Authors:  Arnaldo Zelli; Fabio Lucidi; Luca Mallia
Journal:  Front Psychol       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.